<DOC>
	<DOC>NCT00735046</DOC>
	<brief_summary>A randomized, controlled, parallel-group trial to evaluate the efficacy of a cognitive behavioral therapy for patients with early dementia.</brief_summary>
	<brief_title>Cognitive Behavioural Therapy of Early Dementia</brief_title>
	<detailed_description>The KORDIAL study is a randomized, controlled, parallel-group trial evaluating the efficacy of a cognitive behavioral therapy for patients at the early stage of Alzheimer's disease. The 3-month experimental intervention consists of 12 individual sessions with regular involvement of carers or other patient proxies. Strategies for improving the patient's coping ability and for enhancing their psychological well-being are combined. The primary outcome criterion is functioning in the everyday context after completion of the intervention and after another 6 months. The control condition will be treatment as usual. The study will be conducted in 5 university outpatient units and in 5 specialist offices.</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<criteria>Mild dementia (MMSE &gt; 21) in Alzheimer's disease (ICD10), proxy available Acute of unstable psychiatric or physical disease, proxy unavailable Participation in another trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Early dementia in Alzheimer's disease (MMSE â‰¥ 21)</keyword>
</DOC>